• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期蛋白依赖性激酶4的调控

Regulation of CDK4.

作者信息

Bockstaele Laurence, Coulonval Katia, Kooken Hugues, Paternot Sabine, Roger Pierre P

机构信息

Institute of Interdisciplinary Research (IRIBHM), Faculté de Médecine, Université Libre de Bruxelles, Campus Erasme, B-1070 Brussels, Belgium.

出版信息

Cell Div. 2006 Nov 8;1:25. doi: 10.1186/1747-1028-1-25.

DOI:10.1186/1747-1028-1-25
PMID:17092340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1647274/
Abstract

Cyclin-dependent kinase (CDK)4 is a master integrator that couples mitogenic and antimitogenic extracellular signals with the cell cycle. It is also crucial for many oncogenic transformation processes. In this overview, we address various molecular features of CDK4 activation that are critical but remain poorly known or debated, including the regulation of its association with D-type cyclins, its subcellular location, its activating Thr172-phosphorylation and the roles of Cip/Kip CDK "inhibitors" in these processes. We have recently identified the T-loop phosphorylation of CDK4, but not of CDK6, as a determining target for cell cycle control by extracellular factors, indicating that CDK4-activating kinase(s) might have to be reconsidered.

摘要

细胞周期蛋白依赖性激酶(CDK)4是一个主要的整合因子,它将有丝分裂原性和抗有丝分裂原性细胞外信号与细胞周期联系起来。它对许多致癌转化过程也至关重要。在本综述中,我们探讨了CDK4激活的各种分子特征,这些特征至关重要,但仍鲜为人知或存在争议,包括其与D型细胞周期蛋白结合的调控、亚细胞定位、激活的苏氨酸172磷酸化以及Cip/Kip CDK“抑制剂”在这些过程中的作用。我们最近发现,CDK4而非CDK6的T环磷酸化是细胞外因子控制细胞周期的决定性靶点,这表明可能需要重新考虑CDK4激活激酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8987/1647274/a713da46f686/1747-1028-1-25-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8987/1647274/a713da46f686/1747-1028-1-25-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8987/1647274/a713da46f686/1747-1028-1-25-1.jpg

相似文献

1
Regulation of CDK4.细胞周期蛋白依赖性激酶4的调控
Cell Div. 2006 Nov 8;1:25. doi: 10.1186/1747-1028-1-25.
2
Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".细胞周期蛋白依赖性激酶4(CDK4)的调节性激活苏氨酸172磷酸化:其与细胞周期蛋白和CDK“抑制剂”的关系。
Mol Cell Biol. 2006 Jul;26(13):5070-85. doi: 10.1128/MCB.02006-05.
3
[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].[控制细胞周期的分子机制:基础方面及其对肿瘤学的意义]
Cancer Radiother. 2001 Apr;5(2):109-29. doi: 10.1016/s1278-3218(01)00087-7.
4
Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).五倍子酰葡萄糖通过下调细胞周期蛋白依赖性激酶4(CDK4)和细胞周期蛋白依赖性激酶2(CDK2)的活性以及上调细胞周期蛋白依赖性激酶抑制剂p27(Kip)和p21(Cip)来诱导MCF人乳腺癌细胞的G1期阻滞。
Biochem Pharmacol. 2003 Jun 1;65(11):1777-85. doi: 10.1016/s0006-2952(03)00156-4.
5
JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.JNK通过磷酸化CDK4和p21发挥CDK4激活激酶的作用。
Oncogene. 2017 Jul 27;36(30):4349-4361. doi: 10.1038/onc.2017.7. Epub 2017 Apr 3.
6
Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.使用一系列单克隆抗体对D型细胞周期蛋白依赖性激酶Cdk4和Cdk6进行免疫组织化学分析。
Hybridoma. 1999 Jun;18(3):225-34. doi: 10.1089/027245799315871.
7
Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).转化生长因子β(1)通过阻止细胞周期蛋白D3-细胞周期蛋白依赖性激酶4与细胞核p27(kip1)的结合,选择性抑制原代甲状腺上皮细胞的环磷酸腺苷依赖性增殖。
Mol Biol Cell. 2000 Mar;11(3):1061-76. doi: 10.1091/mbc.11.3.1061.
8
Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.脂肪生成过程中细胞周期蛋白依赖性激酶4的调控涉及细胞周期蛋白D亚基的转换以及p18INK4c和p27Kip1的同时结合。
Cell Growth Differ. 1998 Aug;9(8):595-610.
9
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.细胞周期蛋白依赖性蛋白丝氨酸/苏氨酸激酶抑制剂作为抗癌药物。
Pharmacol Res. 2019 Jan;139:471-488. doi: 10.1016/j.phrs.2018.11.035. Epub 2018 Nov 30.
10
Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes.小鼠肝细胞的化学转化导致细胞周期蛋白D - 细胞周期蛋白依赖性激酶蛋白复合物发生改变。
Carcinogenesis. 1998 Jun;19(6):1093-102. doi: 10.1093/carcin/19.6.1093.

引用本文的文献

1
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.CDK4 磷酸化状态与 CDK4/6 和 BRAF/MEK 抑制联合应用于晚期甲状腺癌的合理选择。
Front Endocrinol (Lausanne). 2023 Oct 26;14:1247542. doi: 10.3389/fendo.2023.1247542. eCollection 2023.
2
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition.细胞周期蛋白依赖性激酶(CDK)4/6在卵巢组织中的作用及其外源性抑制的可能影响。
Cancers (Basel). 2023 Oct 10;15(20):4923. doi: 10.3390/cancers15204923.
3
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges.

本文引用的文献

1
Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.靶向癌症中的细胞周期蛋白和细胞周期蛋白依赖性激酶:来自小鼠的经验教训,对人类治疗应用的期望。
Cell Cycle. 2006 Sep;5(18):2110-4. doi: 10.4161/cc.5.18.3218. Epub 2006 Sep 15.
2
Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes.细胞周期蛋白D3在粒细胞集落刺激因子驱动的中性粒细胞扩增中的重要作用。
Mol Cell Biol. 2006 Nov;26(21):8052-60. doi: 10.1128/MCB.00800-06. Epub 2006 Sep 5.
3
Structure of an Hsp90-Cdc37-Cdk4 complex.
CDK4/6抑制剂在胰胆管癌中的应用:机遇与挑战
Cancers (Basel). 2023 Feb 3;15(3):968. doi: 10.3390/cancers15030968.
4
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.临床前评估 CDK4 磷酸化可预测胸膜间皮瘤对 CDK4/6 抑制的高敏感性。
Mol Oncol. 2024 Apr;18(4):866-894. doi: 10.1002/1878-0261.13351. Epub 2022 Dec 19.
5
Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy.癌细胞周期错乱:异质性、可塑性和治疗。
Trends Cancer. 2022 Sep;8(9):711-725. doi: 10.1016/j.trecan.2022.04.006. Epub 2022 May 20.
6
Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27.针对激活的 CDK4 的单克隆抗体:用于研究正常和癌变细胞周期调控以及 p21 和 p27 磷酸化的参与。
Cell Cycle. 2022 Jan;21(1):12-32. doi: 10.1080/15384101.2021.1984663. Epub 2021 Dec 16.
7
Stabilization of Cyclin-Dependent Kinase 4 by Methionyl-tRNA Synthetase in p16-Negative Cancer.甲硫氨酰 - tRNA合成酶在p16阴性癌症中对细胞周期蛋白依赖性激酶4的稳定作用
ACS Pharmacol Transl Sci. 2018 Apr 24;1(1):21-31. doi: 10.1021/acsptsci.8b00001. eCollection 2018 Sep 14.
8
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer.持续探索乳腺癌中 CDK4/6 抑制剂应答的生物标志物。
Mol Cancer Ther. 2020 Jan;19(1):3-12. doi: 10.1158/1535-7163.MCT-19-0253.
9
Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis.SERTAD1在各类癌症风险中的预后及临床病理意义:一项系统评价与回顾性分析
Cancers (Basel). 2019 Mar 8;11(3):337. doi: 10.3390/cancers11030337.
10
Promotion of Myoblast Differentiation by Fkbp5 via Cdk4 Isomerization.FKBP5 通过 CDK4 异构化促进成肌细胞分化。
Cell Rep. 2018 Nov 27;25(9):2537-2551.e8. doi: 10.1016/j.celrep.2018.11.006.
热休克蛋白90(Hsp90)-细胞周期蛋白依赖性激酶37(Cdc37)-细胞周期蛋白依赖性激酶4(Cdk4)复合物的结构
Mol Cell. 2006 Sep 1;23(5):697-707. doi: 10.1016/j.molcel.2006.07.016.
4
Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.原代培养的人甲状腺细胞在生长因子和促甲状腺激素的不同促有丝分裂刺激中细胞周期蛋白D1和细胞周期蛋白D3的差异利用
Mol Endocrinol. 2006 Dec;20(12):3279-92. doi: 10.1210/me.2005-0515. Epub 2006 Aug 17.
5
Diverse phosphoregulatory mechanisms controlling cyclin-dependent kinase-activating kinases in Arabidopsis.拟南芥中控制细胞周期蛋白依赖性激酶激活激酶的多种磷酸化调节机制。
Plant J. 2006 Sep;47(5):701-10. doi: 10.1111/j.1365-313X.2006.02820.x. Epub 2006 Jul 11.
6
Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".细胞周期蛋白依赖性激酶4(CDK4)的调节性激活苏氨酸172磷酸化:其与细胞周期蛋白和CDK“抑制剂”的关系。
Mol Cell Biol. 2006 Jul;26(13):5070-85. doi: 10.1128/MCB.02006-05.
7
Cdk2 and Cdk4 cooperatively control the expression of Cdc2.细胞周期蛋白依赖性激酶2(Cdk2)和细胞周期蛋白依赖性激酶4(Cdk4)共同调控细胞周期蛋白B1(Cdc2)的表达。
Cell Div. 2006 Jun 6;1:10. doi: 10.1186/1747-1028-1-10.
8
Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.鉴定破坏细胞周期蛋白D1磷酸化依赖性核输出的突变。
Oncogene. 2006 Oct 12;25(47):6291-303. doi: 10.1038/sj.onc.1209644. Epub 2006 May 29.
9
The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression.转录调节因子TRIP-Br家族对于细胞周期蛋白E介导的细胞周期进程的执行至关重要。
Cell Cycle. 2006 May;5(10):1111-5. doi: 10.4161/cc.5.10.2797. Epub 2006 May 15.
10
Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.细胞周期蛋白依赖性激酶2(Cdk2)和细胞周期蛋白依赖性激酶4(Cdk4)的联合缺失导致胚胎致死和视网膜母细胞瘤蛋白(Rb)低磷酸化。
Dev Cell. 2006 May;10(5):563-73. doi: 10.1016/j.devcel.2006.03.004.